Protein kinase antagonists: interim challenges and issues.
Sausville
E A
EA
Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Program, National Cancer Institute, Rockville, MD 21852, USA.
D004791:Enzyme Inhibitors / Q000494:pharmacology*; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism; D013379:Substrate Specificity
D004791:Enzyme Inhibitors; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases